Malignant Tumor Purity Reveals the Driven and Prognostic Role of CD3E in Low-Grade Glioma Microenvironment

Abstract

The tumor microenvironment (TME) contributes to the initiation and progression of many neoplasms. However, the impact of low-grade glioma (LGG) purity on carcinogenesis remains to be elucidated. We selected 509 LGG patients with available genomic and clinical information from the TCGA database. The percentage of tumor infiltrating immune cells and the tumor purity of LGG were evaluated using the ESTIMATE and CIBERSORT algorithms. Stromal-related genes were screened through Cox regression, and protein-protein interaction analyses and survival-related genes were selected in 487 LGG patients from GEO database. Hub genes involved in LGG purity were then identified and functionally annotated using bioinformatics analyses. Prognostic implications were validated in 100 patients from an Asian real-world cohort. Elevated tumor purity burden, immune scores, and stromal scores were significantly associated with poor outcomes and increased grade in LGG patients from the TCGA cohort. In addition, CD3E was selected with the most significant prognostic value (Hazard Ratio=1.552, P<0.001). Differentially expressed genes screened according to CD3E expression were mainly involved in stromal related activities. Additionally, significantly increased CD3E expression was found in 100 LGG samples from the validation cohort compared with adjacent normal brain tissues. High CD3E expression could serve as an independent prognostic indicator for survival of LGG patients and promotes malignant cellular biological behaviors of LGG. In conclusion, tumor purity has a considerable impact on the clinical, genomic, and biological status of LGG. CD3E, the gene for novel membrane immune biomarker deeply affecting tumor purity, may help to evaluate the prognosis and develop individual immunotherapy strategies for LGG patients. Evaluating the ratio of differential tumor purity and CD3E expression levels may provide novel insights into the complex structure of the LGG microenvironment and targeted drug development.

Effect of High-Quality Nursing Based on Comprehensive Nursing on the Postoperative Quality of Life and Satisfaction of Patients with Malignant Glioma

“…Fang et al pointed out that good postoperative nursing can effectively enhance the quality of life of patients [ 18 ]. In the present study, patients receiving high-quality nursing plus comprehensive nursing showed higher quality of life scores versus those only given comprehensive nursing, which was consistent with the relevant research results of the previous research [ 19 ].…”

Radiotherapy-Related Gene Signature in Prostate Cancer

“…A bioinformatics analysis using TCGA data from bladder cancer patients found CD3E to be downregulated in the luminal compared to basal tumor samples, with the luminal subtype being associated with better survival rates. In the same study, CD3E was highlighted as a substantial regulator of the tumor microenvironment, since CD4+ memory T-cells and regulatory T-cells were found to be negatively correlated with CD3E expression levels [ 60 ], while in low-grade glioma patients, CD3E upregulation served as a marker of significantly worse prognosis [ 62 ]. The possibility that downregulation of CD3D and CD3E genes post-RT could be attributed to an RT-based decreasing effect on circulating T-cell frequencies is unlikely since the blood sampling was performed at 3 months post-RT, by which time-point the lymphocyte numbers have been recovered to normal levels pre-RT [ 12 , 13 ].…”

Identification of adenylate cyclase 2 methylation in bladder cancer with implications for prognosis and immunosuppressive microenvironment

“…Cancer immunotherapy, which harnesses the immune system of individuals to fight cancer, has revolutionized cancer treatment strategies. However, the majority of patients show no clinical response, and the mechanisms of resistance remain unclear (35)(36)(37). Therefore, there is an urgent need for novel immunotherapies and therapeutic targets.…”